The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy — University of Texas Southwestern Medical Center Skip to main navigation Skip to search Skip to main content Search All UT System Experts University of Texas Southwestern Medical Center Home Home Profiles Research Units Equipment Research output Search by expertise, name or affiliation The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy Frank I. Marcus, N. A.Marl Estes, Marl S. Link Research output: Contribution to journal › Letter › peer-review 1 Scopus citations Overview Fingerprint Original language English (US) Pages (from-to) 1236 Number of pages 1 Journal American Journal of Cardiology Volume 111 Issue number 8 DOIs https://doi.org/10.1016/j.amjcard.2013.02.017 State Published - Apr 15 2013 Externally published Yes ASJC Scopus subject areas Cardiology and Cardiovascular Medicine Access to Document 10.1016/j.amjcard.2013.02.017 Other files and links Link to publication in Scopus Cite this APA Standard Harvard Vancouver Author BIBTEX RIS Marcus, F. I., Estes, N. A. M., & Link, M. S. (2013). The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy. American Journal of Cardiology, 111(8), 1236. https://doi.org/10.1016/j.amjcard.2013.02.017 The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy. / Marcus, Frank I.; Estes, N. A.Marl; Link, Marl S. In: American Journal of Cardiology, Vol. 111, No. 8, 15.04.2013, p. 1236. Research output: Contribution to journal › Letter › peer-review Marcus, FI, Estes, NAM & Link, MS 2013, 'The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy', American Journal of Cardiology, vol. 111, no. 8, pp. 1236. https://doi.org/10.1016/j.amjcard.2013.02.017 Marcus FI, Estes NAM, Link MS. The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy. American Journal of Cardiology. 2013 Apr 15;111(8):1236. https://doi.org/10.1016/j.amjcard.2013.02.017 Marcus, Frank I. ; Estes, N. A.Marl ; Link, Marl S. / The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy. In: American Journal of Cardiology. 2013 ; Vol. 111, No. 8. pp. 1236. @article{0123338961a64a028b7432aa9299d3b4, title = "The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy", author = "Marcus, {Frank I.} and Estes, {N. A.Marl} and Link, {Marl S.}", note = "Copyright: Copyright 2013 Elsevier B.V., All rights reserved.", year = "2013", month = apr, day = "15", doi = "10.1016/j.amjcard.2013.02.017", language = "English (US)", volume = "111", pages = "1236", journal = "American Journal of Cardiology", issn = "0002-9149", publisher = "Elsevier Inc.", number = "8", } TY - JOUR T1 - The clinical utility of electrophysiological study to predict adverse outcomes in patients with arrhythmogenic right ventricular cardiomyopathy AU - Marcus, Frank I. AU - Estes, N. A.Marl AU - Link, Marl S. N1 - Copyright: Copyright 2013 Elsevier B.V., All rights reserved. PY - 2013/4/15 Y1 - 2013/4/15 UR - http://www.scopus.com/inward/record.url?scp=84875834934&partnerID=8YFLogxK UR - http://www.scopus.com/inward/citedby.url?scp=84875834934&partnerID=8YFLogxK U2 - 10.1016/j.amjcard.2013.02.017 DO - 10.1016/j.amjcard.2013.02.017 M3 - Letter C2 - 23558003 AN - SCOPUS:84875834934 VL - 111 SP - 1236 JO - American Journal of Cardiology JF - American Journal of Cardiology SN - 0002-9149 IS - 8 ER - Powered by Pure, Scopus & Elsevier Fingerprint Engine™ © 2022 Elsevier B.V We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies Log in to Pure About web accessibility